Viewing Study NCT03283202


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2026-01-10 @ 2:27 AM
Study NCT ID: NCT03283202
Status: COMPLETED
Last Update Posted: 2021-04-29
First Post: 2017-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk Factors
Sponsor: Celgene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module